At a cutoff value of the mean HD value plus 2 SD, the BRAT1-Abs positivity rates for the HDs and patients with ESCC, GC, and CRC were 6.3%, 17.9%, 15.6%, and 11.5%, respectively (Table 4). This evidence concerns the gene BRAT1 and esophageal squamous cell carcinoma.